Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4576
Tanger
SKT
$4.33B
| $1.12M | ﹤0.01% |
28,751
-2,000
| -7% | -$80.8K |
|
|
CBM
4577
DELISTED
Cambrex Corporation
CBM
| $1.12M | ﹤0.01% |
25,200
+941
| +4% | +$45.8K |
|
|
BSJG
4578
DELISTED
Guggenheim BulletShares 2016 High Yield Corporate Bond ETF
BSJG
| $1.12M | ﹤0.01% |
43,389
-60,734
| -58% | -$1.57M |
|
|
ARLZ
4579
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $1.12M | ﹤0.01% |
230,733
+167,964
| +268% | +$766K |
|
|
AY
4580
PUT
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $1.12M | ﹤0.01% |
58,800
-6,500
| -10% | -$127K |
|
4581
CALL
Penumbra
PEN
$12.7B
| $1.12M | ﹤0.01% |
14,700
+2,200
| +18% | +$152K |
|
|
XL
4582
CALL
DELISTED
XL Group Ltd.
XL
| $1.12M | ﹤0.01% |
33,200
-21,800
| -40% | -$733K |
|
4583
Global Payments
GPN
$24.3B
| $1.12M | ﹤0.01% |
14,538
-41,158
| -74% | -$3.1M |
|
4584
Dave & Buster's
PLAY
$327M
| $1.11M | ﹤0.01% |
+28,466
| New | +$1.26M |
|
|
KND
4585
CALL
DELISTED
Kindred Healthcare
KND
| $1.11M | ﹤0.01% |
109,000
+6,300
| +6% | +$69.9K |
|
4586
PUT
ManpowerGroup
MAN
$2.9B
| $1.11M | ﹤0.01% |
15,400
-8,300
| -35% | -$572K |
|
4587
PUT
Darling Ingredients
DAR
$10.1B
| $1.11M | ﹤0.01% |
82,300
+39,400
| +92% | +$568K |
|
4588
UMB Financial
UMBF
$11B
| $1.11M | ﹤0.01% |
18,712
-3,428
| -15% | -$196K |
|
|
BGC
4589
PUT
DELISTED
General Cable Corporation
BGC
| $1.11M | ﹤0.01% |
74,200
-24,200
| -25% | -$356K |
|
4590
PUT
Innoviva
INVA
$1.51B
| $1.11M | ﹤0.01% |
101,100
+68,500
| +210% | +$799K |
|
|
BGG
4591
PUT
DELISTED
Briggs & Stratton Corp.
BGG
| $1.11M | ﹤0.01% |
59,500
+25,100
| +73% | +$518K |
|
|
VTTI
4592
CALL
DELISTED
VTTI Energy Partners LP
VTTI
| $1.11M | ﹤0.01% |
58,400
+43,800
| +300% | +$845K |
|
4593
CALL
DNOW Inc
DNOW
$2.88B
| $1.11M | ﹤0.01% |
51,700
+18,000
| +53% | +$360K |
|
4594
CALL
MSC Industrial Direct
MSM
$6.66B
| $1.11M | ﹤0.01% |
15,100
+7,600
| +101% | +$552K |
|
4595
Southern Company
SO
$102B
| $1.11M | ﹤0.01% |
21,600
-35,931
| -62% | -$1.89M |
|
4596
CALL
Assurant
AIZ
$14.1B
| $1.11M | ﹤0.01% |
12,000
+8,500
| +243% | +$743K |
|
|
PUW
4597
DELISTED
Invesco WilderHill Progressive Energy ETF
PUW
| $1.11M | ﹤0.01% |
45,758
-31,254
| -41% | -$733K |
|
4598
PUT
Republic Services
RSG
$68B
| $1.1M | ﹤0.01% |
21,900
+1,600
| +8% | +$82K |
|
4599
PUT
Ingredion
INGR
$6.6B
| $1.1M | ﹤0.01% |
8,300
+4,600
| +124% | +$615K |
|
|
DBD
4600
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.1M | ﹤0.01% |
44,500
-78,000
| -64% | -$2.07M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.